4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030727
SVP, Head of Global Commercial sold 16,334 shares at $45.02 ($735,357)
- SVP, Head of Global Commercial acquired 16,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2018-05-15 | Option exercise | +16,334 | $14.30 | $233,576 | 28,834 | D: show line 1 in the form |
| Porter Derrell SVP, Head of Global Commercial | 2018-05-15 | Sale | −16,334 | $45.02 | $735,357 | 12,500 | D: show line 2 in the form |
| Open-market sales · 16,334 sh · avg $45.02 · $735,357 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2018-05-15 | Option exercise · Employee Stock Option (Right to Buy) | −16,334 | 113,666 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…